Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Infect Dev Ctries ; 7(1): 60-3, 2013 Jan 15.
Article in English | MEDLINE | ID: mdl-23324822

ABSTRACT

Cellulitis is an unusual presentation of cryptococcal infection in renal allograft recipients. In such patients, disseminated cryptococcal infection can result in significant morbidity and mortality. Patients are often treated with antibiotics before a definitive diagnosis is made, delaying appropriate therapy. We describe the case of a 43-year-old post renal transplant recipient presenting with fever and swelling in the right thigh. On physical examination, the patient was found to have features suggestive of cellulitis with minimal slurring of speech. Material obtained from incision and drainage of the wound showed yeast cells resembling Cryptococcus spp. Blood culture and cerebrospinal fluid culture were also found to have growth of Cryptococcus neoformans. He received treatment with amphotericin B 6 mg/kg daily intravenously for two weeks, then continued with fluconazole 400 mg daily for three months. The patient showed a remarkable improvement. There was no recurrence of cryptococcosis after four months of follow-up. The diagnosis of disseminated cryptococcosis should be considered in differential diagnosis of cellulitis among non HIV immunocompromised hosts. A high clinical suspicion and early initiation of therapy is needed to recognize and treat patients effectively.


Subject(s)
Cellulitis/diagnosis , Cryptococcosis/diagnosis , Cryptococcus neoformans/isolation & purification , Cryptococcus/isolation & purification , Kidney Transplantation/adverse effects , Adult , Amphotericin B/therapeutic use , Antifungal Agents/therapeutic use , Cellulitis/drug therapy , Cellulitis/microbiology , Cryptococcosis/drug therapy , Cryptococcosis/microbiology , Cryptococcus/drug effects , Cryptococcus neoformans/drug effects , Diagnosis, Differential , Fluconazole/therapeutic use , Humans , Immunocompromised Host , Male , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...